SEC Comment Letter for enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053) (NVNO) — May 28, 2019
enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053)
Date: May 28, 2019 · CIK: 0001661053 · Accession: 0000000000-19-009019
AI Filing Summary & Sentiment
Show Raw Text
May 28, 2019
Robert A. Berman
Chief Executive Officer
Hancock Jaffe Laboratories, Inc.
70 Doppler
Irvine, California 92168
Re:Hancock Jaffe Laboratories, Inc.
Draft Registration Statement on Form S-1
Submitted May 15, 2019
CIK No. 0001661053
Dear Mr. Berman:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Thomas Jones at 202-551-3602 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Barry I. Grossman, Esq.